Literature DB >> 3541703

Endotoxin-induced changes in plasma concentrations of thromboxane and prostacyclin in neonatal calves given antiserum to a mutant Escherichia coli (J-5).

D D Morris, G D Bottoms, R H Whitlock, M A Johnson.   

Abstract

Plasma concentrations of the stable hydrolysis products of thromboxane (Tx) A2, TxB2, and prostacyclin (6-keto-prostaglandin F1 alpha; PGF1 alpha) were evaluated in 22 neonatal calves given endotoxin (0.5 microgram/kg) by slow IV infusion over a 5-hour period. The effect of pretreatment with bovine antiserum to a mutant of Escherichia coli O111:B4 (J-5) on plasma concentrations of these eicosanoids was determined. Plasma concentrations of TxB2 and 6-keto-PGF1 alpha were increased in response to endotoxin infusion. The mean plasma concentrations of TxB2 peaked 1 hour after endotoxin infusion began and was significantly increased from base line through 8 hours. Mean plasma 6-keto-PGF1 alpha concentration increased more slowly and was increased from base line only at 2 hours after endotoxin infusion began. Administration of bovine J-5 antiserum had no significant effect on endotoxin-induced thromboxane and prostacyclin production.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3541703

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Pathophysiology of experimental bovine endotoxicosis: endotoxin induced synthesis of prostaglandins and thromboxane and the modulatory effect of some non-steroidal anti-inflammatory drugs.

Authors:  N Jarløv; P H Andersen; M Hesselholt
Journal:  Acta Vet Scand       Date:  1992       Impact factor: 1.695

2.  Dose-response relationship for the antipyretic effect of meloxicam in an endotoxin model in cats.

Authors:  C Justus; J F Quirke
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

3.  Some endotoxin-induced clinical and biochemical changes in plasma of camels (Camelus dromedarius).

Authors:  A M Al-Dughaym
Journal:  Vet Res Commun       Date:  2004-11       Impact factor: 2.459

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.